Bradley Canino

Stock Analyst at Stifel

(3.38)
# 2655
Out of 5,453 analysts
103
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
BDTX Black Diamond Therap...
Maintains: Buy
16 15
2.9 417.24% 5 Mar 7, 2025
ALXO ALX Oncology Holding...
Maintains: Hold
3 2
1.16 29.31% 8 Mar 7, 2025
CGEM Cullinan Therapeutic...
Maintains: Buy
23 19
8.23 130.86% 2 Feb 28, 2025
RLAY Relay Therapeutics
Maintains: Buy
27 23
3.68 525% 5 Feb 27, 2025
ARVN Arvinas
Maintains: Buy
63 51
7.33 595.77% 6 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
70 115
24.61 367.29% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 4
n/a n/a 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
40 41
16.3 151.53% 5 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
26 19
7.63 149.02% 6 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
39 42
51.89 -19.06% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
26.56 50.6% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
76.07 77.47% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
9.9 102.02% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.36 635.29% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
1.93 418.13% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
67 47.76% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
2.63 432.32% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
129.46 0.42% 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
44.01 24.97% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
25.59 -10.12% 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
4.07 489.68% 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022